Search

everythinglearnresearchcommunity

for

Search:↓

Prolactin contributes to hair loss by promoting hair follicle shrinkage and cell death.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

We need more research to better understand human hair follicle stem cells for improved treatments for hair loss and skin cancer.

Hormones significantly affect hair and oil gland function in the skin, and more research is needed on skin-related hormone disorders.

Prolactin affects hair growth cycles and can cause early hair follicle regression.

TCDD speeds up skin barrier formation by increasing certain gene expressions.

Mutant mice help researchers understand hair growth and related genetic factors.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

HFMs can help study hair growth and test potential hair growth drugs.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

The document explains how the male reproductive system works, its role in making testosterone, and how conditions like obesity can disrupt it, leading to low testosterone and fertility issues.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Cyclosporine A may help treat hair loss by blocking a protein that inhibits hair growth.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Compartmentalized organization might be crucial for stem cells to effectively respond to growth or injury.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.

Post-finasteride patients show changed neuroactive steroid levels, possibly causing erectile dysfunction and depression.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Different women's hair and skin glands respond to hormones in varied ways, which can cause unwanted hair growth even with normal hormone levels, and more research is needed to treat this effectively.

Prolactin slows down hair growth in mice.

The document concludes that while there are promising methods to control CRISPR/Cas9 gene editing, more research is needed to overcome challenges related to safety and effectiveness for clinical use.

Certain drugs that block specific enzymes can help treat prostate diseases.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

The conclusion is to use scalp cooling, gentle hair care, and treatments like minoxidil for managing hair loss from chemotherapy, and stresses the need for more research and collaboration in this area.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.